Two new signs of Parkinson's disease have been identified in the brain, making it possible to develop new therapies able to halt the progression of the disease while limiting side effects. The discovery, published in two articles in the journal …
ALS Breakthrough – Parkinson s Drug Safely Slows Disease Progression by Over 6 Months scitechdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scitechdaily.com Daily Mail and Mail on Sunday newspapers.
Ozoralizumab demonstrates a long half-life and favorable pharmacokinetics, as well as sustained efficacy, over 52 weeks in patients with rheumatoid arthritis, according to data published in Arthritis Research & Therapy.